Roles
- Associate Professor of Clinical Anesthesiology
- UHealth Institute for Advanced Pain Management
- Program Director Pain Management
-
Biography
Danielle Bodzin Horn, MD is an Assistant Professor of Clinical Anesthesiology at the University of Miami Miller School of Medicine (UMMSM) and Program Director of the Division of Interventional Pain Medicine Fellowship at Jackson Memorial Hospital (JMH/UMMSM).
Dr. Horn earned her Bachelor of Science degree with a major in Psychology from the University of Florida where she graduated summa cum laude and subsequently earned her Doctor of Medicine (MD) from the University of Miami Miller School of Medicine. She completed her residency in Anesthesiology at JMH/UMMSM where she was awarded the honor of chief resident and then continued her training at JMH/UMMSM to complete her fellowship in Pain Medicine. She is double board-certified in Pain Medicine and Anesthesiology by the American Board of Anesthesiology. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
-
Teaching Interests
Pain Medicine, Anesthesiology -
Research Interests
Pain Medicine, Novel treatments for various chronic pain conditions, Quality improvement, Education and Simulation, Patient Safety -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Articles & News
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 2 clinical trials.
-
This is a multicenter, randomized, double-blind, placebo-controlled, Phase 2, proof-of-conceptmaster protocol with appendices to compare independent pain interventions versus placebo.The master protocol? establishes entry criteria for the master protocol? establishes an overarching structure for the disease-state addenda (DSA)? outlines the randomization schema? tests a common hypothesis across multiple indications and interventions, and? facilitates advanced statistical modeling and operational efficiencies.The DSA will contain specific study elements to specific to appropriately define the targetpopulation and unique scales for assessment. The chronic pain disease states of interest currentlyinclude osteoarthritis, chronic low back pain, and diabetic peripheral neuropathic pain. Diseasestateaddenda for additional pain conditions may be added as needed.The master protocol also governs intervention-specific appendices (ISAs). The ISAs? contain study elements specific to the interventions under study, such as dosing regimen,unique eligibility criteria and assessments, or other requirements? may start independently of one another as interventions become available for clinicaltesting, and? may end independently, either when an intervention has concluded, or as interim analysesshow that an interventions criteria for futility or success have been met.
- Principal Investigator: Danielle Bodzin
- Study Phase: Phase II
- Enrollment Status: Not Accepting
-
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
- Principal Investigator: Danielle Bodzin
- Study Phase: Phase 3
- Enrollment Status: Closed